ID: ALA3970691

Max Phase: Preclinical

Molecular Formula: C15H17N3O2

Molecular Weight: 271.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cccc(-c2ncn(/C=C\C(=O)OC(C)C)n2)c1

Standard InChI:  InChI=1S/C15H17N3O2/c1-11(2)20-14(19)7-8-18-10-16-15(17-18)13-6-4-5-12(3)9-13/h4-11H,1-3H3/b8-7-

Standard InChI Key:  ZPMKPASGUYOHQI-FPLPWBNLSA-N

Associated Targets(Human)

Exportin-1 375 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 271.32Molecular Weight (Monoisotopic): 271.1321AlogP: 2.68#Rotatable Bonds: 4
Polar Surface Area: 57.01Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.71CX LogP: 3.76CX LogD: 3.76
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.63Np Likeness Score: -0.98

References

1.  (2011)  Nuclear transport modulators and uses thereof, 

Source